Holdings
ACT Capital Partners, L.P.
As of Sep 30, 2026, ACT Capital Partners, L.P. reported 53 positions worth US$139M. Largest: Chevron Corporation, Krystal Biotech, Inc. and TG Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Chevron Corporation | 75,000 | US$15.3M | first report | Sep 30, 2026 |
| Krystal Biotech, Inc. | 42,000 | US$14M | first report | Sep 30, 2026 |
| TG Therapeutics, Inc. | 237K | US$13.2M | first report | Sep 30, 2026 |
| Amazon.com, Inc. | 42,500 | US$10.6M | first report | Sep 30, 2026 |
| Abivax SA | 85,000 | US$8.42M | first report | Sep 30, 2026 |
| Viking Therapeutics, Inc. | 220K | US$7.18M | first report | Sep 30, 2026 |
| SK hynix Inc. | 34,700 | US$6.39M | first report | Sep 30, 2026 |
| Arrowhead Pharmaceuticals, Inc. | 94,000 | US$6.15M | first report | Sep 30, 2026 |
| Nektar Therapeutics | 90,400 | US$5.47M | first report | Sep 30, 2026 |
| Tesla, Inc. | 14,800 | US$5.25M | first report | Sep 30, 2026 |